EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter InSync randomized clinical evaluation Results of a randomized, double-blind, controlled trial to assess cardiac resynchronization therapy in heart failure patients



Multicenter InSync randomized clinical evaluation Results of a randomized, double-blind, controlled trial to assess cardiac resynchronization therapy in heart failure patients



Circulation 104(17 Supplement): II 618, October 23




(PDF 0-2 workdays service: $29.90)

Accession: 035349724

Download citation: RISBibTeXText



Related references

Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: The Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Journal of Cardiac Failure 6(4): 369-380, 2000

Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Journal of Cardiac Failure 6(4): 369-380, 2001

Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. American Heart Journal 151(4): 837-843, 2006

Benefit of cardiac resynchronization in elderly patients: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. Journal of Interventional Cardiac Electrophysiology 25(2): 91-96, 2009

Cardiac resynchronization therapy in patients with heart failure and conduction abnormalities other than left bundle-branch block: analysis of the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Clinical Cardiology 27(12): 678-682, 2005

Cardiac resynchronization therapy in patients with heart failure and conduction abnormalities other than left bundle-branch block: Analysis of the multicenter insync randomized clinical evaluation (MIRACLE). Clinical Cardiology 27(12): 678-682, 2004

Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study. International Journal of Cardiology 202(): 349-355, 2016

A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of tezosentan in patients with acute decompensated heart failure and acute coronary syndrome. Circulation 104(17 Supplement): II 762, October 23, 2001

Long term results of Cardiac Resynchronization for heart failure patients The InSync clinical trial. Circulation 100(18 SUPPL ): I 515, Nov 2, 1999

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107(25): 3133-3140, 2003

Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study. European Journal of Heart Failure 4(3): 311-320, 2002

Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial. European Heart Journal 38(9): 648-660, 2016

Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. American Heart Journal 151(2): 288-294, 2006

Cardiac resynchronization therapy with the InSync stimulation system improves exercise performance in patients with heart failure MIRACLE trial substudy results. Circulation 104(17 Supplement): II 617-II 618, October 23, 2001

Randomized multicenter double blind placebo controlled evaluation of amlodipine in patients with mild to moderate heart failure. Journal of the American College of Cardiology 17(2 SUPPL A): 274A, 1991